TD Cowen analyst Gary Taylor downgraded Oak Street Health (OSH) to Market Perform from Outperform with a price target of $39, up from $34. CVS Health’s (CVS) definitive agreement to acquire the company for $39 per share in an all-cash transaction is pending.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH:
- Oak Street Health reports FY22 revenue $2.16B, consensus $2.15B
- Oak Street Health downgraded to Neutral from Overweight at JPMorgan
- Oak Street Health downgraded to Market Perform from Outperform at Bernstein
- Oak Street Health downgraded to Market Perform from Outperform at Raymond James
- CVS Health price target raised to $143 from $130 at Jefferies